Older adults who live in economically disadvantaged neighborhoods spend significantly fewer days at home in the year after a ...

FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July 2025 ...

For decades, osteoporosis has meant a slow, one way slide toward fragile bones and fracture risk, managed but rarely truly ...

The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

UPF scientists have discovered this 7% of critical areas based on their pioneering analysis model that allows minimizing the ...

One major warning sign of osteoporosis is a “fragility fracture”—a broken bone caused by something minor like a simple fall.

Fibular fractions are among the quickest forms of leg break to heal, as the fibula are the smaller of the two lower leg bones ...

But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

Kansas City Chiefs QB Patrick Mahomes' knee injury is more complex than the initial reporting may have suggested, and one ...

Abstract: Bone fracture is a very common medical issue faced by medical practitioners, and fracture detection is quite crucial for treatment. Till now, the most popular diagnosing method for bone ...

The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a ...